Acetaminophen - Rugby Laboratories

Manufacturer
Rugby Laboratories
Effective date
2026-08-18
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
daily-update
Hydrated at
2026-08-21 02:01:13

Label at a glance#

ProductAcetaminophen
Active ingredientACETAMINOPHEN
Label structure10 sections

Indications and uses

temporarily reduces fever and relieves minor aches and pains caused by • headache • muscular aches • the common cold • toothache • premenstrual and menstrual cramps • backache • minor pain of arthritis

Dosage and administration

• do not take more than directed (see overdose warning) adults and children 12 years and over: • take 2 tablets every 6 hours while symptoms last • do not take more than 6 tablets in 24 hours, unless directed by a doctor • do not take for more than 10 days unless directed by a doctor children under 12 years: ask a doctor

Label contents#

Full prescribing information#

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (in each tablet)

Acetaminophen 500 mg

Purpose

OTC - PURPOSE SECTION

Pain reliever/fever reducer

Uses

INDICATIONS & USAGE SECTION

temporarily reduces fever and relieves minor aches and pains caused by

• headache

• muscular aches

• the common cold

• toothache

• premenstrual and menstrual cramps

• backache

• minor pain of arthritis

Warnings

WARNINGS SECTION

Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take:

• more than 4,000 mg of acetaminophen in 24 hours

• with other drugs containing acetaminophen

• 3 or more alcoholic drinks every day while using this product

Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include: • skin reddening • blisters • rash

If a skin reaction occurs, stop use and seek medical help right away.

Do not use

OTC - DO NOT USE SECTION

• with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.

• if you are allergic to acetaminophen or any of the inactive ingredients in this product

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have liver disease

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin

OTC - STOP USE SECTION

Stop use and ask a doctor if

• pain gets worse or lasts more than 10 days

• fever gets worse or lasts more than 3 days

• new symptoms occur

• redness or swelling is present

These could be signs of a serious condition.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

Overdose warning:

OVERDOSAGE SECTION

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Directions

DOSAGE & ADMINISTRATION SECTION

• do not take more than directed (see overdose warning)

adults and children 12 years and over:

• take 2 tablets every 6 hours while symptoms last

• do not take more than 6 tablets in 24 hours, unless directed by a doctor

• do not take for more than 10 days unless directed by a doctor

children under 12 years: ask a doctor

Other information

OTHER SAFETY INFORMATION

store in a dry place at 15° – 30°C (59° – 86°F).

Inactive ingredients

INACTIVE INGREDIENT SECTION

corn starch, povidone, sodium starch glycolate, stearic acid.

Questions or comments?

OTC - QUESTIONS SECTION

Call 1-800-231-4670

SPL UNCLASSIFIED SECTION

DO NOT USE IF PRINTED SEAL UNDER CAP IS BROKEN OR MISSING

DISTRIBUTED BY:
RUGBY® LABORATORIES
INDIANAPOLIS, IN 46268

(800) 616-2471

www.major-rugby.com

*Rugby Laboratories is not affiliated with the owner of the registered trademark Tylenol®.

Rev. 01/26 R-29 Re-order No. 370597

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Rugby®

NDC 0536-1172-01

compare to active ingredient in extra strength Tylenol®*

extra strength

acetaminophen

acetaminophen 500 mg

extra strength pain reliever/fever reducer

aspirin free

100 tablets

Rugby labelRugby label

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130305361172015GTIN-13: 0305361172015
EAN-13: 0305361172015
GTIN-12: 305361172015
UPC-A: 305361172015
GTIN storage (14 digits): 00305361172015
5427-100G-Rugby Lab-A4_LBL R54283.jpg

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0536-1172-01EA - Each0536-1172f30304ac-97a9-421a-a77c-c731f4437d2512018-11-06
0536-1172-10EA - Each0536-11726e2522e7-6495-4491-b77c-0a609723c21b12018-11-06

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0536-11720536-1172-10, 0536-1172-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
32024-01-11full-release2026-06-01 00:07:02

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AcetaminophenACETAMINOPHENRugby Laboratories76f10ee2-1d6a-097c-e053-2991aa0af5262026-08-18WarningsExact identifier
ndc (package): 0536-1172-01
ndc (package): 0536-1172-10
ndc (product): 0536-1172
ndc11 (package): 00536117201
ndc11 (package): 00536117210
spl id: 5955a2e7-baa6-8b4e-e063-6394a90acbb7
spl set id: 76f10ee2-1d6a-097c-e053-2991aa0af526

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.